Compound information
- Natural Products
- ZC719539
- Molecular Formula
- C21H30N4O4S
- Molecular Weight
- 434.19877644 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-N-(4-pyrrolidin-1-ylsulfonylphenyl)propanamide
- InChI
- InChI=1S/C21H30N4O4S/c1-16(23-12-14-24(15-13-23)21(27)17-4-5-17)20(26)22-18-6-8-19(9-7-18)30(28,29)25-10-2-3-11-25/h6-9,16-17H,2-5,10-15H2,1H3,(H,22,26)/t16-/m1/s1
- InChI Key
- GQQBONDFOFRLKQ-MRXNPFEDSA-N
- SMILES
- C[C@H](C(=O)Nc1ccc(S(=O)(=O)N2CCCC2)cc1)N1CCN(C(=O)C2CC2)CC1
- Source
- ZINC000035286807
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 4 |
Heteroatom Count | 9 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 90.03 Å2 | LogP | 1.384 |
LogS | -2.936 | LogD | 1.815 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.007 | Pgp substrate | 0.977 |
HIA | 0.969 | F20 % | 0.993 |
F30 % | 0.882 | Caco-2 | -4.815 |
MDCK | -5.205 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.539 | PPB | 86.762 |
VD | 1.011 | Fu | 0.47 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.011 | CYP1A2 substrate | 0.442 |
CYP2A6 substrate | 0.49 | CYP2B6 substrate | 0.722 |
CYP2C19 inhibitor | 0.214 | CYP2C19 substrate | 0.777 |
CYP2C8 substrate | 0.654 | CYP2C9 inhibitor | 0.078 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.098 |
CYP2D6 substrate | 0.847 | CYP2E1 substrate | 0.183 |
CYP3A4 inhibitor | 0.062 | CYP3A4 substrate | 0.996 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.183 | CL | 5.084 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.046 | Hepatotoxicity | 0.433 |
Mutagenicity | 0.006 | Rat Oral Acute Toxicity | 0.228 |
FDAMDD | 0.522 | Skin Sensitization | 0.525 |
Carcinogenicity | 0.246 | Eye Corrosion | 0.002 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.306 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.461 | IGC50 | 2.54 |
LC50FM | -17.249 | LC50DM | -2.815 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.354 | NR-AR-LBD | 0.349 |
NR-AhR | 0.062 | NR-Aromatase | 0.02 |
NR-ER | 0.183 | NR-ER-LBD | 0.361 |
NR-PPAR-gamma | 0.109 | SR-ARE | 0.347 |
SR-ATAD5 | 0.29 | SR-HSE | 0.064 |
SR-MMP | 0.013 | SR-p53 | 0.107 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.